Every mid-tier restructuring shop in London looks across the Atlantic and sees El Dorado. They watch the big four accounting giants stumble, watch private equity pile into distress situations, and think a flag in New York or Chicago turns them into a global player. Interpath Advisory wants its own US deal. Everyone in the trade press is nodding along like this is the natural next chapter of a corporate fairy tale.
It is a vanity play disguised as strategy.
I have watched British and European professional services firms burn tens of millions of pounds trying to buy their way into the American market. They assume cross-border referrals happen automatically once you share a brand name or a conference room in Midtown. They ignore the graveyard of transatlantic expansions where partners hate each other, billing rates clash, and the cultural disconnect between Chancery Lane and Manhattan destroys the very talent they paid a fortune to acquire.
Buying a US firm right now does not solve Interpath’s growth problem. It accelerates friction.
The Myth of the Transatlantic Bridge
The lazy consensus in professional services holds that scale equals survival. If you are not in the United States, you cannot service global private equity funds. If you cannot service those funds, you get squeezed out of billion-dollar cross-border mandates.
This logic falls apart the moment you look at actual deal economics.
American restructuring and advisory is an entirely different beast compared to the UK market. The US operates under Chapter 11, a litigious, court-driven marathon that rewards massive debtor-in-possession networks and institutional bankruptcy law firm relationships. UK administration is relatively streamlined, administrator-centric, and heavily tied to domestic lending syndicates.
When a mid-sized UK firm drops fifty or a hundred million dollars on a US bolt-on, they are not buying instant market share. They are buying a collection of expensive partners who expect US-scale compensation packages while bringing zero guaranteed debtor-in-possession pipelines.
I have seen firms blow millions on US footprints only to realize their new American partners view them as an overseas ATM rather than a strategic partner. The incentives misalign instantly. US restructuring partners eat what they kill based on local court relationships. They do not care about sending turnaround work to Manchester or Birmingham.
What the Press Gets Wrong About Cross-Border Dealflow
Financial journalism loves a geographic expansion story. It gives editors a neat map to draw and a narrative about ambition. But the modern enterprise client does not care about your global office count. They care about sector depth and conflict clearance.
When a multinational corporation hits the wall, they want the sharpest specialist who can navigate their specific operational mess, not a generic mid-market brand that happens to have a token office in Texas.
Interpath has carved out a brilliant niche in the UK post-private-equity boom by staying fiercely independent, highly operational, and unburdened by the legacy conflicts of the Big Four. The moment you buy a US firm, you inherit a maze of independence checks, regulatory headaches, and partner politics that dilute your core DNA.
Expansion without domestic dominance is just dilution. Interpath should be deepening its grip on European secondary buyouts and operational turnaround mandates where it actually holds pricing power. Instead, the board is getting seduced by the bright lights of Wall Street.
The Economics of Cultural Rejection
Let us talk about the integration math nobody publishes in the press releases.
Imagine a scenario where Interpath acquires a fifty-person boutique restructuring practice in New York. You pay a multiple of EBITDA, lock up the key rainmakers with three-year retention earn-outs, and pop the champagne.
Month four arrives. The London office wants to standardize internal reporting metrics, utilization targets, and compliance software. The New York partners laugh. They are used to higher billing rates, different administrative support structures, and a cutthroat eat-what-you-kill compensation model that makes British partnership tiers look like a socialist commune.
By month eighteen, the top-billing US rainmaker realizes their earn-out is tracking poorly because the cross-border referrals are flowing one way—out of London, with nothing coming back. They start taking calls from rival US mega-firms. By month thirty-six, the retention lock expires, the rainmakers walk across the street taking their client lists with them, and you are left holding an empty corporate shell in Manhattan with a multi-million-dollar goodwill impairment on your balance sheet.
I have watched this exact play happen to three different European advisories over the last decade. The script never changes.
The Alternative Playbook
If I were sitting in Interpath’s boardroom, the US acquisition budget would be incinerated immediately.
True international leverage in advisory does not require owning foreign real estate or paying US partner draws. It requires an alliance network built on ruthless competence, not equity ownership.
Partner with elite, independent US boutiques that have zero desire to build a global network of their own. Give them your European overflow work; take their US inbound mandates. Keep your balance sheet liquid. Keep your equity concentrated among people who actually talk to each other across lunch tables.
Scale that doesn't compound profit per equity partner is just an expensive vanity project for the CEO's resume.
Stop buying offices. Start dominating the markets where you actually know how to win.
